Jun Wang

Prof. Jun Wang

Orthodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan, China
orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2022 in Bioactive Materials
Verified
Journal Article
Open access
YLYazhen Li
Yazhen Li
LYLu Yang
Lu Yang
YHYue Hou
Yue Hou
ZZZhenzhen Zhang
Zhenzhen Zhang
MCMiao Chen
Miao Chen
XLXiong Lu
Xiong Lu
Regenerating periodontal bone tissues in the aggravated inflammatory periodontal microenvironment under diabetic conditions is a great challenge. Here, a polydopamine-mediated graphene oxide (PGO) and hydroxyapatite nanoparticle (PHA)-incorporated conductive alginate/gelatin (AG) scaffold is developed to accelerate periodontal bone regeneration by modulating the diabetic inflammatory microenvironment. PHA confers the scaffold with osteoinductivity and PGO provides a conductive pathway for the scaffold. The conductive scaffold promotes bone regeneration by transferring endogenous electrical signals to cells and activating Ca2+ channels. Moreover, the scaffold with polydopamine-mediated nanomaterials has a reactive oxygen species (ROS)-scavenging ability and anti-inflammatory activity. It also exhibits an immunomodulatory ability that suppresses M1 macrophage polarization and activates M2 macrophages to secrete osteogenesis-related cytokines by mediating glycolytic and RhoA/ROCK pathways in macrophages. The scaffold induces excellent bone regeneration in periodontal bone defects of diabetic rats because of the synergistic effects of good conductive, ROS-scavenging, anti-inflammatory, and immunomodulatory abilities. This study provides fundamental insights into the synergistical effects of conductivity, osteoinductivity, and immunomodulatory abilities on bone regeneration and offers a novel strategy to design immunomodulatory biomaterials for treatment of immune-related diseases and tissue regeneration.

26 February 2021 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
ZJZhanrong Jia
Zhanrong Jia
JGJinglei Gong
Jinglei Gong
YZYan Zeng
Yan Zeng
JRJinhui Ran
Jinhui Ran
JLJing Liu
Jing Liu
Jun WangJun Wang
Jun Wang

25 September 2021 in Cell Proliferation
Verified
Journal Article
Open access
PDF file
XZXueman Zhou
Xueman Zhou
YZYingcheng Zheng
Yingcheng Zheng
WSWentian Sun
Wentian Sun
ZZZhenzhen Zhang
Zhenzhen Zhang
JLJiaqi Liu
Jiaqi Liu
JLJin Liu
Jin Liu
Objectives: Chondrocyte ferroptosis contributes to osteoarthritis (OA) progression, and D‐mannose shows therapeutic value in many inflammatory conditions. Here, we investigated whether D‐mannose interferes in chondrocyte ferroptotic cell death during osteoarthritic cartilage degeneration.Materials and methods: In vivo anterior cruciate ligament transection (ACLT)‐induced OA mouse model and an in vitro study of chondrocytes in an OA microenvironment induced by interleukin‐1β (IL‐1β) exposure were employed. Combined with Epas1 gene gain‐ and loss‐of‐function, histology, immunofluorescence, quantitative RT‐PCR, Western blot, cell viability and flow cytometry experiments were performed to evaluate the chondroprotective effects of D‐mannose in OA progression and the role of hypoxia‐inducible factor 2 alpha (HIF‐2 α) in D‐mannose‐induced ferroptosis resistance of chondrocytes.Results: D‐mannose exerted a chondroprotective effect by attenuating the sensitivity of chondrocytes to ferroptosis and alleviated OA progression. HIF‐2α was identified as a central mediator in D‐mannose‐induced ferroptosis resistance of chondrocytes. Furthermore, overexpression of HIF‐2α in chondrocytes by Ad‐Epas1 intra‐articular injection abolished the chondroprotective effect of D‐mannose during OA progression and eliminated the role of D‐mannose as a ferroptosis suppressor.Conclusions: D‐mannose alleviates osteoarthritis progression by suppressing HIF‐2α‐mediated chondrocyte sensitivity to ferroptosis, indicating D‐mannose to be a potential therapeutic strategy for ferroptosis‐related diseases.

15 February 2013 in Oral Diseases
Verified
Journal Article
Closed access
PDF file
ZLZ Li
Z Li
CJC‐M Jiang
C‐M Jiang
SAS An
S An
QCQ Cheng
Q Cheng
YHY‐F Huang
Y‐F Huang
Jun WangJun Wang
Jun Wang

21 October 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
XFXinyi Fang
Xinyi Fang
Jun WangJun Wang
Jun Wang
CYChengxinyue Ye
Chengxinyue Ye
JLJiu Lin
Jiu Lin
JRJinhui Ran
Jinhui Ran
JLJin Liu
Jin Liu
Excessive oxidative response, unbalanced immunomodulation, and impaired mesenchymal stem cell function in periodontitis in diabetes makes it a great challenge to achieve integrated periodontal tissue regeneration. Here, a polyphenol-mediated redox-active algin/gelatin hydrogel encapsulating a conductive poly(3,4-ethylenedioxythiopene)-assembled polydopamine-mediated silk microfiber network and a hydrogen sulfide sustained-release system utilizing bovine serum albumin nanoparticles is developed. This hydrogel is found to reverse the hyperglycemic inflammatory microenvironment and enhance functional tissue regeneration in diabetic periodontitis. Polydopamine confers the hydrogel with anti-oxidative and anti-inflammatory activity. The slow, sustained release of hydrogen sulfide from the bovine serum albumin nanoparticles recruits mesenchymal stem cells and promotes subsequent angiogenesis and osteogenesis. Moreover, poly(3,4-ethylenedioxythiopene)-assembled polydopamine-mediated silk microfiber confers the hydrogel with good conductivity, which enables it to transmit endogenous bioelectricity, promote cell arrangement, and increase the inflow of calcium ion. In addition, the synergistic effects of hydrogen sulfide gaseous-bioelectric coupling promotes bone formation by amplifying autophagy in periodontal ligament stem cells and modulating macrophage polarization via lipid metabolism regulation. This study provides innovative insights into the synergistic effects of conductivity, reactive oxygen species scavenging, and hydrogen sulfide on the periodontium in a hyperglycemic inflammatory microenvironment, offering a strategy for the design of gaseous-bioelectric biomaterials to promote functional tissue regeneration in immune-related diseases.

29 June 2010 in Cell Proliferation
Verified
Journal Article
Open access
PDF file
JLJ Li
J Li
ZZZ Zhao
Z Zhao
JLJ Liu
J Liu
NHN Huang
N Huang
DLD Long
D Long
YLY Liu
Y Liu
Objectives:  This study was carried out to reveal functions and mechanisms of MEK/ERK and p38 pathways in chondrogenesis of rat bone marrow mesenchymal stem cells (BMSCs), and to investigate further any interactions between the mitogen‐activated protein kinase (MAPK) and transforming growth factor‐β1 (TGF‐β1)/Smads pathway in the process.Materials and methods:  Chondrogenic differentiation of rat BMSCs was initiated in micromass culture, in the presence of TGF‐β1, for 2 weeks. ERK1/2 and p38 kinase activities were investigated by Western Blot analysis. Specific MAPK inhibitors PD98059 and SB20350 were employed to investigate regulatory effects of MEK/ERK and p38 signals on gene expression of chondrocyte‐specific markers, and TGF‐β1 downstream pathways of Smad2/3.Results:  ERK1/2 was phosphorylated in a rapid but transient manner, whereas p38 was activated in a slow and sustained way. The two MAPK subtypes played opposing roles in mediating transcription of cartilage‐specific genes for Col2α and aggrecan. TGF‐β1‐stimulated gene expression of chondrogenic regulators, Sox9, Runx2 and Ihh, was also affected by activity of PD98059 and SB203580, to different degrees. However, influences of MAPK inhibitors on gene expression were relatively minor when not treated with TGF‐β1. In addition, gene transcription of Smad2/3 was significantly upregulated by TGF‐β1, but was regulated more subtly by treatment with MAPK inhibitors.Conclusions:  MAPK subtypes seemed to regulate chondrogenesis with a delicate balance, interacting with the TGF‐β1/Smads signalling pathway.